Aurinia Pharmaceuticals (AUPH) Cash from Operations (2020 - 2026)

Aurinia Pharmaceuticals has reported Cash from Operations for 7 years, with the latest figure at 32560000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 2404.62% year-over-year to 32560000.0; the trailing twelve-month figure through Mar 2026 stood at 166918000.0 (up 159.65% YoY), and the FY2025 full-year result was 135658000.0, up 205.62% from the prior year.
• Cash from Operations for Q1 2026 stood at 32560000.0, down from 45668000.0 in the prior quarter.
• The five-year high for Cash from Operations was 45668000.0 in Q4 2025, with the low at 46746000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 5859764.71 across 5 years, with a median of 10450000.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash from Operations climbed 12.69% — and 2026, when it soared 2404.62%.
• Aurinia Pharmaceuticals' Cash from Operations stood at 10450000.0 in 2022, then soared by 36.96% to 14312000.0 in 2023, then surged by 110.41% to 30114000.0 in 2024, then jumped by 51.65% to 45668000.0 in 2025, then decreased by 28.7% to 32560000.0 in 2026.
• The last three Cash from Operations figures came in at 32560000.0 (Q1 2026), 45668000.0 (Q4 2025), and 44449000.0 (Q3 2025), per Business Quant data.